glp 1 patents GLP-1 Patent Landscape: Who Leads the Innovation Race Pharma or Food? Medicines Patent Pool Executive Director
Description
No, I dont look like I did 10 years ago
Insulin secretagogues (sulfonylureas and meglitinides) are associated with an increased cardiovascular risk due to their inhibiting effect on ATP-sensitive potassium channels in the cardiovascular system [127]
John Evan, Global Demand for Semaglutide: Which Countries Are Driving Sales
Injectable GLP-1 drugs also must be stored in the fridge, which may put off some people who find this reduces privacy and convenience, compared with taking a pill
